Literature DB >> 27993812

Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status.

G Roviello1, C Pacifico2, K Polom3, F Roviello3, D Generali4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27993812     DOI： 10.1093/annonc/mdw657

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study.

Authors:  Maria Di Bartolomeo; Monica Niger; Giuseppe Tirino; Angelica Petrillo; Rosa Berenato; Maria Maddalena Laterza; Filippo Pietrantonio; Federica Morano; Maria Antista; Sara Lonardi; Lorenzo Fornaro; Stefano Tamberi; Elisa Giommoni; Alberto Zaniboni; Lorenza Rimassa; Gianluca Tomasello; Teodoro Sava; Massimiliano Spada; Tiziana Latiano; Alessandro Bittoni; Alessandro Bertolini; Ilaria Proserpio; Katia Bruna Bencardino; Francesco Graziano; Giordano Beretta; Salvatore Galdy; Jole Ventriglia; Simone Scagnoli; Andrea Spallanzani; Raffaella Longarini; Ferdinando De Vita
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.